$591 | SAVE $104 | Single User
$2423 | SAVE $427 | Multi User
$4803 | SAVE $847 | Global License

Building Effective Health Economic Outcomes Research Teams

Building Effective Health Economic Outcomes Research (HEOR) Teams
[Lowest Price Guaranteed: $591]

Published by FirstWord Pharma: 01 May 2016 | 65248 | In Stock
Related Topics: Healthcare , Investment , Medical , Technology , Vaccine

Introduction

How to build an effective health economic and outcomes research team

Health Economic and Outcomes Research (HEOR) teams play a critical market access role from refining clinical research and building a brand’s value proposition to informing post-marketing reviews. As the demands of payer, regulator and Health Technology Assessment (HTA) agencies grow, what does a modern and effective HEOR team look like in 2016?

This expert report analyses the growing pressure points on HEOR teams and identifies the essential staff talents, organisational positioning, external providers and evaluation criteria needed to deliver persuasive HEOR in a demanding market.

“The role of HEOR is to enable long-term market access to therapies, not only the strict cost-utility analysis but going further and helping market access teams to provide an understanding of the value of a therapy.”

Vice President, Market Access, Health Policy and Medical Affairs

Top 10 Vaccines Manufacturer

Answering key questions

Payer/HTA pressures: Growing and specific payer/HTA requests for data and supporting evidence is demanding on an HEOR team’s time. How can companies optimise their resources?

Where’s the money? Investment in HEOR is increasing, but demands and workloads are expanding even faster. Can pharma get a head of the funding curve?

Early engagement: How, when and why should pharma involve HEOR teams in clinical research planning?

HEOR Organisation: Medical affairs? Market access? Does it matter?

Outside help: In what circumstances can external consultants bring value to HEOR and what are the key management issues concerning their engagement?

Skills gap: How can you recruit, train, reward and retain hard-to-come-by HEOR staff and should employers be looking beyond health economists for talent?

Performance Management: What evaluation techniques and metrics can be employed to measure HEOR team performance?

Key Topics Explored

Payer/HTA demands for specific evidence and data is outstripping pharma’s investment in HEOR. Given its importance for commercial success, isn’t it time pharma rethought the level of investment in HEOR?

Finding staff that combine good technical skill with capabilities for delivering complex data persuasively to multiple stakeholders is a big ask. Where should recruiters be looking and what are the essential skills needed?

Opinion differs about where HEOR should sit organisationally, but cross-functional teams are critical to achieving the end result.

Not just bean counters: evaluating HEOR team members and team performance needs to look at much more than activity levels, so what are the options for measuring success?

Expert Contributors

Expert contributors to this report include senior HEOR and market access professionals working in leading pharma companies. To ensure candid views were expressed their identities have been kept anonymous.

A Vice President, Market Access, Health Policy and Medical Affairs within a top 10 vaccine manufacturer

A Senior Vice President, Global Regulation, Healthcare Policy and Corporate Affairs within a top 50 global pharmaceutical manufacturer

A Senior Health Economics and Outcomes Research Manager, UK and Ireland within a top 50 global pharmaceutical manufacturer

A Senior Director, Global Outcomes & Epidemiology within a top 50 global pharmaceutical manufacturer

A Health Economics Director, Europe, within a top 50 global pharmaceutical manufacturer

A Vice President, Health Economics and Outcomes Research within a top 10 global pharmaceutical manufacturer

A Head of Market Access, Oncology, UK, within a top 10 global pharmaceutical manufacturer

A Director, Medical Policy-Access Research at a top 10 global pharmaceutical manufacturer

About FirstWord

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.

FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.

FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.

Table of Contents
for Building Effective Health Economic Outcomes Research (HEOR) Teams

  • 1.Executive Summary

    2.Research Objectives and Methodology

    3.Setting the scene

    3.1.Key findings

    3.2.Increasing demand for HEOR

    3.2.1.The rise of payers

    3.2.2.HEOR helps demonstrate value to payers

    3.2.3.HEOR crucial for access and commercial success

    3.2.4.Successful companies have skilled HEOR teams

    3.2.5.HEOR vital in Europe

    3.3.Industry has responded to the demands for HEOR

    3.4.Increase in HEOR workload predicted

    4.The HEOR team

    4.1.Key findings

    4.2.Investing in HEOR

    4.2.1.Development of dedicated HEOR teams

    4.2.2.Building the team to reflect the pipeline and portfolio

    4.2.3.Lean HEOR teams

    4.3.Capabilities and skills needed in the HEOR team

    4.3.1.Challenging to recruit to HEOR teams

    4.3.2.Qualifications are sought after, but experience counts

    4.3.3.The goal is to have well-rounded HEOR teams

    4.3.4.Soft skills crucial even in a technical team like HEOR

    4.4.Responsibilities of the HEOR team

    4.4.1.Not just for models and HTA.

    4.4.2.Identifying and filling evidence gaps

    4.4.3.Submission to HTA agencies and ongoing engagement

    4.4.4.Going further than submissions: shaping policy

    4.4.5.HEOR teams have to explain their HTA strategy internally

    4.5.1.Training and support

    4.5.2.Bring in the right people from the start

    4.5.3.Tailor training to the needs of individuals

    4.5.5.Invest in communication skills

    5.HEOR over the product lifecycle

    5.1.Key findings

    5.2.HEOR crucial throughout the life cycle of a product

    5.2.1.Early involvement of HEOR

    5.2.2.HEOR involvement crucial going into Phase III

    5.2.3.HEOR work intensifies in the run-up to launch

    5.2.4.Still work to be done post launch

    6.HEOR and engaging with payers

    6.1.Key findings

    6.1.1.HEOR teams often support colleagues who work with budget holders

    6.1.2.HEOR teams liaise with HTA agencies

    7.Performance management and incentives for HEOR teams

    7.1.Key findings

    7.2.The challenge of measuring the impact of HEOR

    7.3.Evolution in performance metrics: from deliverables to impact

    7.4.Rewarded just like other staff at the company

    5.HEOR within the broader structure of companies

    5.1.Key findings

    5.2.Diverse approaches to reporting

    5.3.Cross-company working key

    6.The balance between in-house and out‑of-house

    6.1.Key findings

    6.2.Outsourcing provides key support to HEOR teams

    7.HEOR in the future

    7.1.Key findings

    7.2.HEOR will remain crucial but will need to change

Additional Details

Publisher

FirstWord Pharma

Publisher Information

Reference

65248 |

Report Format

PDF

FirstWord Pharma Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Epoxy Adhesives Market by Type (One-component, Two-component), Application (Building & Construction, Transportation, Automotive, Wind Energy, Marine, Electrical & Electronics), and Region - Global Forecast to 2026
“The global market for epoxy adhesives is projected to grow at a CAGR of 6.63% from 2016 to 2026”The...
02 Dec 2016 by MarketsandMarkets USD $7,650 (normally
USD $9,000)
More Info
SAVE 15% today! Welding Materials Market by Type (Electrode & Filler Materials, Fluxes & Wires, Gases), End-Use Industry (Transportation, Building & Construction, Heavy Industries), Technology (ARC, Resistance, OXY-Fuel Welding), and Region - Global Forecast to 2021
Welding materials market is projected to reach USD 15.80 billion by 2021 The welding materials marke...
16 Sep 2016 by MarketsandMarkets USD $4,803 (normally
USD $5,651)
More Info
SAVE 15% today! Fog Computing Market by Offering (Hardware, Software), Application (Building & Home Automation, Smart Energy, Smart Manufacturing, Transportation & Logistics, Connected Health, Security & Emergencies), and Geography - Global Forecast to 2022
“Growing Internet of Things is expected to drive the fog computing market during the forecast period...
12 Sep 2016 by MarketsandMarkets USD $4,803 (normally
USD $5,651)
More Info
SAVE 15% today! Polyurethane Adhesives Market by Technology (Solventborne, Reactive, Dispersion, and Hot Melt), Type (Thermoset & Thermoplastic), Application (Building & Construction, Packaging, Automotive, Footwear, Electrical & Electronics, and Furniture) - Global Forecast to 2021
“Polyurethane adhesives market to register a CAGR of 6.8% between 2016 and 2021” The market size of ...
08 Sep 2016 by MarketsandMarkets USD $4,803 (normally
USD $5,651)
More Info
SAVE 15% today! Concrete Repair Mortars Market by Type (Polymer-Modified Cementitious Mortar and Epoxy-Based Mortar), Application Method (Manual, Spraying, and Pouring), End-use Industry (Building & Car Park, Road & Infrastructure, Utility Industries) - Global Forecast to 2021
“Increasing spending on repair and maintenance building & infrastructure drives the concrete repair ...
30 Aug 2016 by MarketsandMarkets USD $4,803 (normally
USD $5,651)
More Info
SAVE 15% today! Building Effective Health Economic Outcomes Research (HEOR) Teams
IntroductionHow to build an effective health economic and outcomes research teamHealth Economic and ...
01 May 2016 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Building Strong Cross-Functional Medical Affairs Teams
IntroductionCould your Medical Affairs team be better integrated for more effective cross-functional...
01 May 2015 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Asia-Pacific Ethylene Propylene Diene Monomer Market by Application (Automotive, Building & Construction, Plastic Modification, Tires & Tubes, Wire & Cables, Lubricant Additive, Others) by Geography — Forecasts to 2019
The report provides insights into the important ethylene propylene diene monomer markets in the Asia...
14 Apr 2015 by MicroMarketMonitor USD $2,253 (normally
USD $2,651)
More Info
SAVE 15% today! North American Ethylene Propylene Diene Monomer market by Application (automotive, building & construction, plastic modification, tires & tubes, wire & cables, lubricant additive, and others) & Country — Forecasts to 2019
The report includes the important Ethylene Propylene Diene Monomer North American markets. It furthe...
13 Apr 2015 by MicroMarketMonitor USD $2,253 (normally
USD $2,651)
More Info
SAVE 15% today! Pharma and Payers – Building Better Relationships
IntroductionChanges in the healthcare landscape have put payers (public and private) under mounting ...
01 Sep 2012 by FirstWord Pharma USD $591 (normally
USD $695)
More Info

This report is published by FirstWord Pharma

Download Free Report Summary PDF

Building Effective Health Economic Outcomes Research (HEOR) Teams | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...